FROGG #6 Genitourinary Sessions for Radiation Oncology Trainees, Supported by Mundipharma (Eligard)
Topic: Systemic Management of Prostate Cancer – Current agents and horizon scanning Learning outcomes/objectives: Defining current treatment of metastatic hormone-sensitive prostate cancer including recent clinical trials. Outlining current management of metastatic castration-resistant prostate cancer. Discussing future directions in systemic treatment of metastatic prostate cancer. Guest speakers: -  Dr Louise Kostos MBBS (Hons), FRACP. Consultant Medical. Oncologist and PhD student. Peter MacCallum Cancer Centre. Louise is a Medical Oncologist at the Peter MacCallum Cancer Centre in the genitourinary team. She has a particular interest in prostate cancer and early-phase clinical trials. Currently, Louise is currently undertaking a PhD in advancing outcomes for men with castration resistant prostate cancer who receive radionuclide therapy. - A/Prof Arun Azad MBBS PhD FRACP Associate Professor Arun Azad is an internationally recognised medical oncologist and translational researcher in urological cancers, with a particular focus on prostate cancer.
Default Presenter
11/22/2021 8:00:00 AM

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Sonic Foundry